Related Experiment Video
Updated: Jan 10, 2026

03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.1K
Cardiomyocyte Nuclear Pleomorphism in a Mouse Model of Inherited Hypertrophic Cardiomyopathy
Jamie R Johnston1, Isabella Leite Coscarella1, Carson L Rose2
1Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL 32306, USA.
Journal of Cardiovascular Development and Disease
|November 26, 2025
Summary
Pathogenic mutations in sarcomeric genes, like TNNc1, cause hypertrophic cardiomyopathy (HCM). This study links myofilament dysfunction to altered cardiomyocyte nuclei shape and protein content in a TNNc1-p.A8V mouse model.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cellular Biology
Background:
- Mutations in sarcomeric protein genes are a primary cause of human cardiomyopathies and sudden cardiac death.
- Troponin C (cTnC) is crucial for cardiomyocyte calcium regulation and sarcomere function.
- The TNNc1-p.A8V mutation models hypertrophic cardiomyopathy (HCM), impacting cardiac muscle contractility and gene expression.
Purpose of the Study:
- To investigate the hypothesis that myofilament dysfunction, caused by the TNNc1-p.A8V mutation, is associated with morphological and functional changes in cardiomyocyte nuclei.
- To explore the relationship between sarcomeric protein mutations, nuclear morphology, and protein composition within cardiomyocyte nuclei.
Main Methods:
- Utilized a TNNc1-p.A8V knock-in mouse model of hypertrophic cardiomyopathy.
- Performed histological analysis of myocardial tissue and isolated cardiomyocytes to assess nuclear morphology (size, shape).
- Employed immunoblotting to analyze protein expression and localization (cardiac troponin C, histone H4) in heart tissue and nuclei.
Main Results:
- TNNc1-p.A8V mouse hearts exhibited significantly smaller and rounder cardiomyocyte nuclei compared to wild-type controls.
- Nuclear morphological changes were independent of cardiomyocyte size or ploidy.
- Decreased nuclear localization of cardiac troponin C and reduced histone H4 expression were observed in mutant hearts.
Conclusions:
- Pathological myofilament dysfunction resulting from cardiomyopathy-associated mutations can lead to altered cardiomyocyte nuclear morphology.
- Aberrant nuclear protein composition and shape changes are linked to sarcomeric gene mutations in hypertrophic cardiomyopathy.
- Findings suggest a potential role for cardiomyocyte nuclei in the pathogenesis of HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
378
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
378
Cardiomyopathy I: Introduction and Classification
483
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
483

